Literature DB >> 21252525

Light chain-mediated tubulopathies.

Paul W Sanders1.   

Abstract

Immunoglobulin light chains are low molecular weight proteins that are filtered through the glomerulus and reabsorbed into the proximal tubular epithelium by binding initially to a heteromeric receptor complex composed of megalin and cubilin. Saturation of this receptor-mediated endocytotic process results in the presence of free light chains in the distal nephron and urine. In the course of metabolism of monoclonal light chains, nephrotoxicity can occur, resulting in clinical manifestations that can include acute kidney injury and progressive chronic kidney disease. Patterns of tubulopathic renal injury include proximal tubular epithelial cell cytotoxicity, tubulointerstitial nephritis and cast nephropathy (also known as 'myeloma kidney'). Research efforts over the past two decades have refined understanding of the molecular mechanisms involved in light chain-mediated tubular injury and are the subject of this review.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21252525     DOI: 10.1159/000313959

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  4 in total

1.  Free light chains injure proximal tubule cells through the STAT1/HMGB1/TLR axis.

Authors:  Rohit Upadhyay; Wei-Zhong Ying; Zannatul Nasrin; Hana Safah; Edgar A Jaimes; Wenguang Feng; Paul W Sanders; Vecihi Batuman
Journal:  JCI Insight       Date:  2020-07-23

Review 2.  Acute tubulointerstitial nephritis.

Authors:  Tim Ulinski; Anne-Laure Sellier-Leclerc; Elena Tudorache; Albert Bensman; Bilal Aoun
Journal:  Pediatr Nephrol       Date:  2011-06-03       Impact factor: 3.651

Review 3.  Extracellular vesicles mediate cellular interactions in renal diseases-Novel views of intercellular communications in the kidney.

Authors:  Ping L Zhang; Ming-Lin Liu
Journal:  J Cell Physiol       Date:  2021-01-11       Impact factor: 6.513

4.  Case report on renal failure reversal in lambda chain multiple myeloma with bortezomib and dexamethasone.

Authors:  Bhanu K Patibandla; Akshita Narra; Ahmad A Alwassia; Anthony Bartley; Gurprataap S Sandhu; James Rooney; Robert M Black
Journal:  Case Rep Nephrol       Date:  2014-06-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.